Argenica Therapeutics Ltd (AGN)

Sydney
0.74
-0.03(-3.90%)
  • Volume:
    521,310
  • Bid/Ask:
    0.71/0.74
  • Day's Range:
    0.71 - 0.85

AGN Overview

Prev. Close
0.77
Day's Range
0.71-0.85
Revenue
-
Open
0.77
52 wk Range
0.18-1.02
EPS
-0.01
Volume
521,310
Market Cap
56.34M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
214,101
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
73,172,250
Next Earnings Date
-
What is your sentiment on Argenica Therapeutics Ltd?
or
Market is currently closed. Voting is open during market hours.

Argenica Therapeutics Ltd Company Profile

Employees
0
Market
Australia

Argenica Therapeutics Limited researches and develops a neuroprotective therapeutic drug in Australia. The company’s product is ARG-007, a neuroprotective peptide candidate for use in the protection of brain tissue against damage during a stroke and other acute central nervous system injuries. Argenica Therapeutics Limited was incorporated in 2019 and is based in Nedlands, Australia.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellNeutralStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellSellStrong Buy
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.